Research Topic

Large U.S. study compares hospitalization rates in unvaccinated, vaccinated and vaccinated plus booster dose individuals

New analysis finds vast majority of Canadian clinical trials aren’t prospectively registering, reporting their results, and publishing their findings.

With an ongoing phase 3 study, pralsetinib seems to be a promising candidate for the treatment of different types of cancer because of the presence of oncogenic rearranged during transfection) fusions.

Adjusting for demographics and hours/weeks of work, we found that on average female physicians earn about 9% less than their male counterparts, finds health economist Boris Kralj.

The dashboard, made by COVID-19 Resources Canada, provides a current analysis of risk broken down by province.

It's the second vaccine to be approved for that age group, after Health Canada approved Moderna's Spikevax shot in July.

Depression, anxiety, worry, perceived stress or loneliness preceding SARS-CoV-2 infection may increase risk of developing “long” COVID symptoms.